Thapsigargin (Tg), a specific inhibitor of sarco/endoplasmic Ca 2+ -ATPases (SERCA), binds with high affinity to the E2 conformation of these ATPases. SERCA inhibition leads to elevated calcium levels in the cytoplasm, which in turn induces apoptosis. We present X-ray crystallographic and intrinsic fluorescence data to show how 
Thapsigargin (Tg), a specific inhibitor of sarco/endoplasmic Ca 2+ -ATPases (SERCA), binds with high affinity to the E2 conformation of these ATPases. SERCA inhibition leads to elevated calcium levels in the cytoplasm, which in turn induces apoptosis. We present X-ray crystallographic and intrinsic fluorescence data to show how Tg and chemical analogs of the compound with modified or removed side chains bind to isolated SERCA 1a membranes. This occurs by uptake via the membrane lipid followed by insertion into a resident intramembraneous binding site with few adaptative changes. Our binding data indicate that a balanced hydrophobicity and accurate positioning of the side chains, provided by the central guianolide ring structure, defines a pharmacophore of Tg that governs both high affinity and access to the protein binding site. Tg analogs substituted with long linkers at O-8 extend from the binding site between transmembrane segments to the putative Nterminal Ca 2+ entry pathway. The long chain analogs provide a rational basis for the localization of the linker the presence of which is necessary for enabling prostate specific antigen (PSA) to cleave peptide conjugated prodrugs targeting SERCA of cancer cells (Denmeade et al. J Natl Cancer Inst 95, 990-1000). Our study demonstrates the usefulness of a simple in vitro system to test and direct development toward the formulation of new Tg derivatives with improved properties for SERCA targeting. Finally, we propose that the Tg binding pocket may be a regulatory site which is sensitive to e.g. cholesterol.
Understanding protein-membrane interaction and the activity of lipophilic drugs and specific lipids like sterols attracts increasing attention and represents a challenge to our current models of protein-solvent interactions and protein dynamics. Sarco/endoplasmic Ca 2+ -ATPase (SERCA) offers an attractive model for the analysis of such interactions due to favourable biochemical properties with sensitive assays of function, a large resource of inhibitors and a wealth of crystal structures related to the functional cycle. In conjunction with plasma membrane Ca 2+ -ATPases and Ca 2+ channel proteins SERCA orchestrates spatiotemporal changes in the concentration of Ca 2+ inside the cell, providing the background essential for the function of Ca 2+ as a second messenger in the regulation of numerous cellular processes (1-3). At the same time, high cytosolic (>1µM) concentrations of Ca 2+ , induced by depletion of the endoplasmic Ca 2+ stores and uptake of extracellular Ca 2+ by the endoplasmic store regulated mechanism (4) are involved as essential factors in the induction of apoptotic processes, leading to mitochondrial disruption with release of cytochrome c, activation of intracellular caspases, and cell death (5) . As a consequence, interference of cellular function by inhibition of SERCA may lead to apoptotic cell death irrespective of the proliferative status of the cell. In this connection Thapsigargin (Tg 1 , compound I, see Fig. 1 ) is of particular interest as a specific inhibitor of SERCA. Tg is a sesquiterpene lactone, present in the Mediterranean umbelliferous plant, Thapsia garganica. Tg has been shown to bind to the E2 form of SERCA (6-9) with very high affinity at a transmembrane site located at the protein-lipid interphase between the M3, M5 and M7 (10,11). The target specificity and potency makes Tg very valuable for studies on the cell physiological role of SERCA (12) and also has enrolled the compound in the development of a prodrug strategy for killing prostate cancer cells (13) . Targeting is based on the ability of prostate cells to express the protease PSA on the cell surface (14) . By conjugating Tg, substituted with a 12−amino-dodecyllinker at O-8 to a peptide possessing the C-terminal amino acid sequence His-Ser-Ser-Lys-Gln-Leu a prodrug has been obtained that is unmasked by specific cleavage of the Gln-Leu peptide bond. The released Tg derivative is immediately taken up by the prostate cancer cells, leading to their demise over a few days (13). We previously described how a related Tg analog with a tert-butoxycarbonyl-12-aminododecanoyl linker (Boc-12-ADT) interacts with the ATPase after cocrystallization and determination of the structure by X-ray diffraction at low resolution (15) . We found that this compound is bound in the Tg binding cavity of SERCA 1a, but quite surprisingly with the hydrophobic methylene groups of the linker penetrating the membrane sector of the protein by insertion between the transmembrane helices 3 and 5, with the hydrophilic Boc group ending close to the region of the second Ca 2+ binding site (15) . In the present communication we investigate the basis for the high affinity interaction of SERCA 1a with Tg by comparison with the structure of the binding site and affinity of many Tg analogs with modified or desubstituted side chains. In this way our study has pinpointed the factors that are crucial for the interaction of these compounds with SERCA and resolved a number of questions concerning the role of precise location and orientation of the side chains and of the hydrophobic properties of the compounds in the formation of the Tg pharmacophore as well as for the interaction with the lipid phase of the membrane. This has led not only to a deeper understanding of the affinity and specificity of the Tg-SERCA interaction, but our data may also serve as a rationale for development of new drugs with improved properties for targeting of Ca 2+ ion pumps.
Materials and Methods
Chemical syntheses -Tg, selectively radiolabeled in the butanoate side chain of the molecule, was prepared by 3 H-catalyzed reduction after substitution of the 8-O-butanoyl group of Tg with but-3-enoyl (16) . The resulting product was found to contain ~ 10 % impurities that, unlike authentic Tg did not bind to Ca 2+ -ATPase membranes or hydrophobic surfaces. A scheme of the Tg analogs used is shown in figure 1. Tg analog dOTg (II, Fig 1) and dATg (III), was synthesized as previously described (17) . DTB (VI) was prepared by esterification of 8-Odebutanoylnortrilobolide with dodecanoic acid using dicyclohexyl-carbodiimide as a catalyst. Boc-ϕTg (VIII), was prepared by esterification of 8-O-debutanoyl Tg (IV) with 3-(5-tertiarybutoxycarbonylaminopentyl)-4-methoxymethoxy phenylpropanoate. The synthesis of this acid involved a Friedel-Craft reaction between ethyl 4-methoxyphenylpropionic acid and 5-phtalimidopentanoyl chloride to give the carbon skeleton. A series of protections and deprotections of the functional groups was needed to get the target compound. These reactions are described in details in the Supplementary Material (Schemes S1a -1c 4 and 4% v/v tert-butanol. Single, squared crystals appeared after a few days and grew to a maximum size of 250 × 250 × 50 µm within a couple of weeks. The crystals were mounted with a bent litho loop (Molecular Dimensions) and stabilised by transferring them shortly to a solution consisting of 2 µL reservoir buffer and 1 µL of 50% v/v glycerol before flash-cooling in liquid nitrogen. Diffraction data for the crystals were collected at the Swiss Light Source (SLS) beamline X06SA and the European Synchrotron Radiation Facility (ESRF) at beamline ID23-1. The E2(dOTg) diffraction data were processed with the HKL2000 package and for the E2(DTB) and the E2(Boc-φTg) data with the XDS package to 3.1Å, 2.65 Å and 3.1 Å resolution, respectively, all in the space group P4 1 2 1 2. Modelling -The crystallographic data obtained from the E2(dOTg), E2(DTB) and E2(Boc-φTg) complex were isomorphous to data of the E2(Tg):AMPPCP complex (pdb code 2C8K). The structures were accordingly determined on the basis of the E2(Tg):AMPPCP structure (with , 10 mM Tes (pH 7.5), and 100 mM KCl. Activities were then measured spectrophotometrically by addition of 10 µL of the pre-equlibrated mixture to a cuvette, containing 3 ml of an ATP regenerating assay medium in 0.1 mM Ca 2+ , 1 mM Mg 2+ , 5 mM MgATP, 1 mM phosphoenolpyruvate and other additions for spectrophotometric registration of enzyme activity (24) . The inhibitor (Tg or Tg derivative), solubilized in DMSO, was added cumulatively to the ATPase pre-equilibration mixture in increments of usually 0.2 -0.4 mol/mg protein. Examples of the inhibition curves obtained and their evaluation in terms of K d (50 % inhibition of activity), are shown in Fig. S4 . We found that the gradual increase in inhibitor concentration sample, effectuated by the incremental addition, facilitated the attainment of binding equilibrium after each step, which especially for analogs with long hydrocarbon tails often was a slow process, requiring up to 6 min preincubation after each addition (as also evidenced from slow inhibitor induced changes in intrinsic fluorescence). The pre-incubation of ATPase with inhibitor and the use of glassware instead of plastic, was also done to avoid as much as possible unspecific adsorption of inhibitor during the assay. Changes in intrinsic (tryptophan) fluorescence were recorded on a Shimadzu RF5301 spectrofluorometer with continuous stirring in a thermostatted cuvette at 23 o C. The protein concentration was 50 µg/ml, and measurements were made with the monochromators set at 290 and 335 nm as the excitatory and emission wavelengths, respectively. Phosphorylation by ATP-γ 32 P and 45 Ca 2+ binding measurements was as previously (25) performed by Millipore filtration.
Results

Thapsigargin-Ca
2+ -ATPase structure and interaction -In Fig. 2 we have explored the effect of Tg binding on the structure of Ca 2+ -ATPase in the E2 state. A detailed comparison was possible, since several crystal forms are available of this state, with and without bound Tg (Fig. S3) , and the comparison of the Tg binding site applies also to the E2 forms described below in this paper. As can be seen from Fig Fig. 2D we have superimposed two of our E2 structures in the E2-P like transition state solved in the presence and absence of Tg. In the presence of Tg the binding cavity is slightly larger because of movements of some of the amino acid side chains to accommodate the bound inhibitor. Thus, the side chain of Phe 256, which from mutational evidence has been identified as a key residue in the binding of Tg (26, 27) , is rotated backwards into the transmembrane region, to establish the correct position for stacking of the phenyl group against the central cycloheptane and γ-lactone ring of the Tg tricyclic guaianolide nucleus. Furthermore, Gln 259 is rotated 180 degrees outwards to allow for accommodation of Tg inside the cavity, while Phe 834 undergoes a slight rotation in the opposite direction, combined with a small cytosolic shift, probably to realize a favourable interaction between the phenyl ring and the carbonyl group of the acetoxy group of Tg at O-10. (17) the carbonyl and hydroxyl groups of Tg are not in register for hydrogen bond formation with hydrogen bond donating or accepting groups on the protein. Thus, the binding bears all the hallmarks of being hydrophobic in nature. However, a theoretical GRID analysis performed with a methyl probe suggests a localized nature of the hydrophobic interactions, hydrophobic molecular interaction fields mainly being present corresponding to the O-3 angeloyl, the C-4 methyl, the O-8 butanoyl, and O-10 acetyl-substituents, while similar interactions appear to be absent from the tricyclic ring structure (17) . We have experimentally approached these questions by activity measurements where we have tested the effect of the side chains on the binding affinity after their systematic removal from Tg. These desubstituted derivatives were prepared by previously described methods (17, 28, 29) , but we note that the unavailability of desoctanoyl Tg forced us to use as a model compound, the previously described dihydronortribolide, which differs from desoctanoyl Tg by having a saturated bond between C-4 and C-5 (30) . From the activity/inhibitor concentration curves we find for all desubstituted compounds substantial reductions in the affinity, from a subnanomolar value (0.2 nM) for unmodified Tg, to 3.5 -113 nM after loss of the side chains. The third and fourth rows of -ATPase with the separately spaced Tg side chains. According to these calculations less contribution will come from the guianolide tricyclic ring, its major role being to serve as a scaffold to bring the side chains in correct position for hydrophobic interactions inside the binding cavity (17, 30) . In a previous study Wictome et al. (32) assigned an important role of the lactone ring to the binding mechanism based on a drastic (µmolar) reduction in binding affinity upon dehydration of the OH-7 and OH-11 groups. This is a conclusion that is only partly confirmed by our studies, because although we do find a decreased binding affinity by ring opening and other modifications of the lactone ring, these changes will also affect the spatial configuration of the side chains and are generally not larger than observed here by their removal. Role of lipid phase for binding of ThapsigarginDue to its hydrophobic properties Tg can be expected to partition into the membraneous lipid phase. Would this occur independent of protein binding (i.e. in a kinetic scheme by a parallel reaction pathway) -or does binding occur in series with a preceding uptake by the lipid phase? With the aid of tritiated Tg we have attempted to resolve questions concerning the role of the lipid phase for the interaction with Tg as shown by the chromatographic data in Fig. 3 . As can be seen from Fig. 3A Tg, when reacted with stoichiometric amounts of Ca 2+ -ATPase in the E2 conformation (presence of 1 mM EGTA), remains firmly bound to the membranes, being only slowly eluted by passage through a long Sephadex column. However, almost the same amount of Tg remains attached to membranes in the Ca 2 E1 conformation, following chromatography in the presence of 0.5 mM Ca 2+ (Fig. 3B) . Since Tg does not react with Ca 2+ -ATPase under the conditions of the latter experiment, this is an indication of binding by the lipid phase. In accordance with this conclusion Tg was also retained by lipid after addition of Tg to unilamellar DOPC liposomes (Fig. 3C) , irrespective of whether these were eluted in the presence of EGTA or Ca
2+
. Thus, it is clear that Tg regardless of its interaction with Ca 2+ -ATPase is avidly taken up by the lipid membrane phase, from which it is only removed with difficulty by chromatography. Therefore, the first step in binding of Tg at the protein site can be proposed to take place by interaction with the membrane lipid phase from which the compound in a following step moves into the protein binding site, obviating a much more difficult access via the cytoplasmic interphase. Furthermore, we found that the ATPase is capable of interacting with the tritiated Tg after solubilization by C 12 E 8 and HPLC in the presence of C 12 E 8 (Fig. 3D ). Under these conditions the tritiated label partitioned between the detergent solubilized and delipidated E2-ATPase monomer and the mixed micelles of C 12 E 8 and SR-lipid. The molar binding ratio of Tg to Ca 2+ -ATPase under these conditions was estimated to be 1.2 ± 0.3. Activity tests with C 12 E 8 ATPase indicated a dissociation constant of 10 nM, i.e. around a 50 times decrease in binding affinity. Thus, these data substantiate the important role of the membrane lipid not only in mediating contact with the binding site, but also in modulating the affinity of Tg at the binding site. Binding of dOTg -Overall, the decreased affinity of the desubstituted Tg analogs (Table 1) fits well with the result of the previous GRID analysis (17) , but with one exception, that of dOTg for which subnanomolar affinity was predicted, similar to that of Tg, due to the absence of interaction of the octanoyl group with the protein. However, it is clear from the Tg-SERCA structure that the octanoyl group is located in a position where instead of interacting with the protein it is expected to react with the lipid at the protein-lipid interphase. In agreement with these considerations, X-ray diffraction analysis of cocrystals of ATPase with dOTg shows that binding of the central ring structure and remaining side groups is only slightly affected in comparison with Tg (Fig. 2E,F,G) . Thus the additional affinity with which Tg is bound, compared to dOTg (Table 1) , can probably be attributed to interaction with membrane lipid. As will be shown below dOTg also reacts with Ca 2+ -ATPase with different kinetics. (15) . By cocrystallization we have now at 2.65 and 3.1 Å resolution also determined the structure of DTB and Boc-φTg (compound VIII, with a phenol group incorporated into the side chain), respectively,. Unbiased (F obs -F obs ) isomorphous difference and model-based (F obs -F calc ) difference Fourier maps combined with comparisons of refined structures (Figs. S1 and S2) provide our basis for discussing the structural details of the binding of these analogs as illustrated in Fig. 4 . We find that the central ring structure of both analogs is bound in basically the same way as Tg between the M3, M5, and M7 transmembrane segments. However, by superimposition of the structures with Tg ( Figs 4A-B) it can be seen that the upper puckered 7-membered ring and the lactone ring is slightly pushed outwards, while the lower fivemembered ring is slightly moved inwards as compared to Tg. The overall structures that Ca 2+ -ATPase adopt in complex with these compounds are practically unchanged, as indicated by r.m.s. deviations of 0.52-0.8 Å for Cα atoms, compared to a number of other Tg bound structures (PDB 2C8K, 2DQS and 2AGV, Fig. S3 ). But the most remarkable feature of these structures is that the long side chain at O-8 is internally located, penetrating between transmembrane helices of Ca 2+ -ATPase membrane helices, starting at a crevice forming between M3 and M5 as was previously reported for Boc-12ADT (15). For both DTB and Boc-φTg the first part of the O-8 side chain, like the butanoyl group of Tg, moves upwards in the cytosolic direction towards the above mentioned crevice. Here the further course of the long chain linkers is changed towards the inside of the ATPase transmembrane domain. For DTB the hydrocarbon chain during the intramembranous course gradually disappears in the electron density maps, probably due to the inherent flexibility of the dodecyl chain in the hydrophobic environment between M3, M4, and M5 segments (Fig. S1B and S2B) . However, for the less flexible Boc-φTg ( Fig. S1C and S2C) we find that the phenol ring (incorporated at its 2 and 4 position) forms a rigid and defined bend at the crevice that by displacing the side chain of Val 253 inserts between M3 and M5 and directs the linker towards the N-terminal region of the pump. During this traverse the intervening hydrocarbon chain proceeds in front of M4 close to Glu 309 of the 308 PEGLP motif that is involved in Ca 2+ binding at site II, and ends close to the kink region of M1. This region forms part of the putative entrance for cytosolic Ca 2+ binding (Fig. 4C-F) . The location of the last part of the chain with the Boc group is also close to the head group of the phospholipid present in a cavity between M2 and M4 and overlaps with the binding site of BHQ (33) (Fig. 4E ) and CPA (34) (35) (36) (Fig. 4F) , other well known inhibitors of Ca 2+ transport. This closely defined course, obtained with a less flexible linker is consistent with the insertion previously deduced for the linker with the Boc-12ADT analog (15) .
Inhibitory effects and binding of Thapsigargin and analogs to Ca
2+ -ATPase -The dissociation constants (defined as the concentration of free inhibitor giving 50 % inhibition of activity) for the seven analogs with long side chains at O-8 range from 1.3 -48 nM as shown in the third column of Table 2 . Especially, the side chain linkers where one ether group has replaced two methylene groups in the dodecyl linker (compounds IX and X) retain high affinity. Surprisingly, the inhibition of Ca 2+ -ATPase by Boc-12ADT, the structure for interaction with Ca 2+ -ATPase we previously published (15) , is much less efficient (48 ± 4 nM) than that of Tg and the other analogs. The much smaller effect of Boc-12ADT was somewhat unexpected, since the analog with Leu-12ADT linker previously was reported to be as efficient as Tg in producing apoptosis in prostate cancer cell lines (29) . The sluggishness of Boc-12ADT may have to be considered in connection with the slow kinetic features of the compound in the interaction with SERCA as indicated by data presented below. The kinetics of the binding of the compounds were registered by the decrease in the intrinsic tryptophan fluorescence of Ca 2+ -ATPase accompanying the interaction (Fig. 5) . Despite that Tg is bound with extraordinarily high affinity the time course of the binding can easily be followed, because it proceeds slowly over a period of minutes with a rate constant around 1 min -1 to ATPase in the E2 conformation (Fig.  5A) . The interaction is slightly longer for binding to ATPase in the Ca 2 E1 state (3.5 min -1 ) where it is accompanied by the concomitant release of two Ca 2+ ions (Fig. 5C ). By contrast, the decrease in fluorescence observed by interaction of dOTg with E2 is instantaneous, while the interaction of the compound with Ca 2 E1 is biphasic, consisting of one instantaneous and one slow phase, each of which is accompanied by the release of one Ca 2+ ion (cf. Fig 5C, and Fig. 5B ). Most of the O-8 linkers (with the exception of DTB and Boc-12ADT) react with E2 in a biphasic reaction modus, but are inefficient in displacing more than one bound Ca 2+ from Ca 2 E1, findings which we attribute to the existence of an intermediate CaE form that is only incompletely converted to E2, as can be rationalized with the aid of the ramified reaction scheme shown in Fig. 5D . DTB is bound slowly, both to E2 and Ca 2 E1, effects that are probably accounted for on the basis of slow incorporation of the unsubstituted dodecyl chain into the membraneous domain. An even slower interaction is obtained with Boc-12ADT which requires 1 -2 hrs for completion, and where the interaction can only be detected as slow reductions in the Ca 2+ -binding (Fig. 5C ), while no changes in intrinsic fluorescence are observed, apart from a tiny increase occurring immediately after the addition, a feature that is also revealed with the aid of the other slowly reacting analog DTB (Fig. 5B) . With Boc-12ADT a slow decrease in the fluorescence response, similar to that of the other analogs is probably not recognized, because it is masked by other time dependent changes in fluorescence such as photolysis.
DISCUSSION
The binding of Thapsigargin to Ca
2+ -ATPaseThe structures of E2 ATPase that we have obtained with or without Tg reveal how Tg with few adaptations fits into a preformed cavity between the third, fifth and seventh transmembrane segment, resulting in stabilization of the protein in a non-Ca 2+ binding E2 conformation. The interaction is mainly of a hydrophobic nature, where high affinity and specificity is achieved, by interaction with hydrophobic aminoacid residues that in accordance with a previous GRID analysis (17) interact with the side chain groups of Tg, brought in accurate position by the tricyclic guianolide nucleus. By these interactions and by stacking with Phe 256 the lactone ring is distorted and together with the upper part of the molecule pressed against the M5 and M3 helices, thereby probably preventing the movements that are necessary for Ca 2+ binding and the E2 → Ca 2 E1 transition. The high affinity binding of Tg is an exclusive property of E2 conformations leaving the cation binding sites in a proton occluded and cytoplasmically oriented state. In accordance with the simulations of Paula and Ball (37), we find that attempts to dock Tg in the Ca 2 E1 structure lead to stereochemical clashes, mainly because the cavity is slightly narrower and the transition to the E1 conformation drives the M3 helix with Phe 256 and other interacting amino acid side chains 5 Å in the cytoplasmic direction. Obviously, these features emphasize the role of complementarity, as a result of which the binding site does not interact well with the slightly different conformation of the binding cavity in the E1 states. Kinetically, the binding reaction appears to occur in at least three stages, during which Tg and analogs are first taken up by the membrane lipid, then forms a presteady state complex at the phospholipid/protein interphase, before finally being adapted within the binding cavity. The extent of hydrophobic interaction with membrane lipid probably is a significant kinetic factor which e.g. accounts for the slow rate (k on ~1 min -1 ) with which Tg interacts with the ATPase. This is also suggested by the rapidity with which the less hydrophobic dOTg reacts with the protein (Fig. 5A) . The formation of the presteady state complex can take place both in the E2 and Ca 2 E1 state and is accompanied by a slight increase in intrinsic fluorescence, a change that is most easily observed with the slowly complexing analogs Boc-12ADT and DTB (Fig.  5) , probably as the result of slow accommodation of their long hydrocarbon chains inside the membrane. The formation of the genuine complex with Ca 2+ -ATPase in the E2 conformation requires some adaptation of the binding site and is accompanied by a distinct decrease in intrinsic (tryptophan) fluorescence. It is of interest that although binding cavities, similar to those for Tg in Ca 
Interaction of Ca
2+ -ATPase with long chain linkers -We find that our new analogs of Tg provided with flexible linkers, substituting for the butanoyl group at O-8 of Tg, are bound in basically the same way as Tg, except that the guaianolide ring structure is less distorted and tilts outwards. Thus some adaptation has taken place within the binding site that probably results in a less intense interaction with amino acid residues in the upper part of the binding pocket. In all cases the linkers are inserted between the M3, M5, and M4 transmembrane segments in a similar way as the aminododecyl side chain of Boc-12ADT (15) . For Boc-ϕTg we demonstrate that the chain proceeds towards the putative Nterminal Ca 2+ entrance region close to the Ca 2+ binding site II in such a way that the terminal Boc group overlaps with that of other well documented Ca 2+ -ATPase inhibitors, CPA (34-36) and BHQ (33) . Our experiments indicate that Boc-12ADT, which has been used as a model for the active component of a prostate cancer cell killing prodrug (13, 40) , is a very slowly working inhibitor of Ca 2+ -ATPase. Boc-12ADT was also much slower than DTB, the nortrilobide analog where the side chain is an unmodified dodecyl group. To account for the slow behaviour of Boc-12ADT we consider that the dodecyl chain due to its strongly hydrophobic and flexible poperties is prevented from extending beyond the hydrophobic barrier separating the terminal Boc group bound at Ca 2+ -binding site II from the Tg binding site. For this purpose the other modified linkers as used here (Table 2 ) may be more appropriate. In particular we found that linkers where one or more oxygen atoms replaced methylene groups were capable of interacting much more rapidly and efficiently with the E2 conformation of Ca 2+ -ATPase than Boc-12ADT. The faster complex formation may be caused by the more amphipathic or other chemical properties of the oxygenated side chain. Physiological and pathophysiological aspectsOur study with SERCA 1a and Tg emphasizes the importance of the lipid phase of membranes as an entrance port for uptake of amphiphatic and lipophilic compounds that after their uptake may affect the function of membrane proteins. Present concepts of membrane protein/lipid interaction suggest that Ca 2+ -ATPase is surrounded by a layer (an annulus) of non-specifically associated lipid as well as endowed with binding of lipid at a few specific (nonannular) sites of probably regulatory significance for the protein (41) . The cavity present between M3, M5, and M7 is a prime candidate for a nonannular site which by its close relation to the Ca 2+ -binding sites would be capable of exerting a regulatory effect on Ca -ATPase with cholesterol/dioleoylphosphatidylcholine mixtures, although with a somewhat lower affinity than phospholipids (41, 45) . However, there is also evidenc from tryptophan quenching studies with a brominated cholesterol derivative that cholesterol is bound more firmly at a specific nonannular binding site (46) . In shark Na + ,K + -ATPase (47) (2ZXE) a cholesterol molecule has been found associated with the enzyme, although at a slightly different position between the α-and β-subunit where the pig kidney enzyme structure also shows a bound bilayer component (47) . With respect to the implications of our study for prostate cancer it will be important to use the detailed knowledge accruing from the binding mechanism of Tg as a guide in the design of new inhibitors, amenable to commercially interesting chemical syntheses, to replace Thapsia garganica as the limited plant resource of potent SERCA inhibitors. This may be feasible with the aid of a fragment based approach (48) by synthesizing compounds where the interacting pharmacophore is built on a central skeleton placing the side chains in approximately the same topological position as in Tg (30) . Furthermore, a linker at O-8 may allow for more flexibility in drug design to target prostate cancer cells by providing inhibitors that in addition to binding at the Tg site also interacts at the same location as CPA and BHQ. These developments should go hand in hand with theoretical docking studies from which a number of the conclusions on the interaction of Tg and analogs, including the presteady binding reported here, were actually previously predicted by theoretical computations without prior experimental evidence (37) . Finally, it should be borne in mind that similar cavities as in SERCA are present in other P-type ATPases. These may also be amenable to the elaboration of specific and individual inhibitors by fragment based approaches. -, PDB code 1XP5) with main chains shown as tubes in blue and yellow color, respectively, and Tg as green sticks with carbon atoms colored green and oxygen atoms colored red. These two structures are representative of all known structures with and without Tg (Fig. S3) . F. Alignment of E2:AMPPCP: dOTg with E2:AMPPCP-Tg (PDB 2C88). Flanked by structural formulas of Tg (E ) and dOTg (G). , was added 15 µM Tg together with A. 1 mM EGTA or B. 0.5 mM Ca 2+ . One ml sample was applied to a 1 x 25 cm Sephadex G50 coarse column pre-equilibrated and eluted at 1 ml/min with the same buffer as used for suspension of the ATPase. Both in the presence of EGTA and Ca 2+ the protein (shown as blue lines) eluted at the void volume after 11-14 min without detectable loss of Tg (shown as red lines) from the membranes. C. There was also complete chromatographic retention of Tg after addition of 15 µM radiolabelled tharsigargin to unilamellar DOPC liposomes (1.5 mg/ml), prepared by reconstitution from cholate and suspended in the same buffer as in B. In D. 3 mg Ca 2+ -ATPase was solubilised by 30 mg C 12 E 8 in 20 mM Tes/Tris (pH 7.0), 100 mM KCl, 1 mM Mg 2+ , 1 mM EGTA, and 20 % (v/v) glycerol, and insoluble residues removed by high speed centrifugation. To the supernatant was added 25 µM labelled Tg, and 0.4 ml was injected into a 0.75 x 30 cm TOSO Haas 3000SWxl HPLC column, equilibrated and eluted at 0.5 ml/min with 1 mg C 12 E 8 /ml in the same buffer as used for solubilisation. In Fig. 3D Peak 1 represents monomeric Ca 2+ -ATPase, and peak 2 the mixed micelles of C 12 E 8 and SR lipid. Notice that Tg which was added in about twice the stoichiometric concentration of active Ca 2+ -ATPase is distributed about equally between the protein and mixed phospholipid/detergent peak. BocφTg is shown in blue sticks and SERCA in wheat cartoon and with stick representations of some of the aminoacid side chain residues surrounding the Boc-φTg ligand and the lipid (PTY) identified in a cavity between M2 and M4 (25) . E. E2-Tg-BHQ (2AGV) taken from Obara et al 2005 (33) . Tg and BHQ is shown in yellow and Boc-ϕTg in marine. F. E2:ADP-CPA (3FPS) with CPA shown in purple and Boc-ϕTg in marine. Notice how the Boc-group of the E2-Boc-ϕTg linker is located in the same binding groove as the inhibitors BHQ (Fig.  4E) and CPA (Fig. 4F) . The positioning of the phosphatidylethanolamine lipid (PTY) within the E2-Boc-ϕTg complex is indicated with a red broken line between the transmembrane helices M2 and M4. A Mg 2+ ion that coordinates CPA (26) is shown in green sphere. A and B) . In A. two additions were made, the first one being 1 mM EGTA, to convert the Ca 2+ -ATPase from the Ca 2+ bound E1 form to E2, followed later by addition of 12 µM inhibitor. In B. the inhibitor (Tg, dOTg, DTB, or Boc-12ADT) was added as indicated, at a concentration of 12 µM in the presence of the Ca 2+ containing medium. C. shows parallel experiments where changes in Ca 2+ binding were measured by Millipore filtration with the aid of radiolabelled 45 Ca 2+ . D. a comprehensive kinetic scheme is shown, with stepwise dissociation of Ca 2+ , used to evaluate the data as described in the text and to analyze the conversion of Ca 2 E1 to E 2 T with bound inhibitor (T) in terms of two apparent rate constants (k′ and k′′) assembled in Table 2 . Tables   Table 1 , 10 mM Tes/Tris (pH 7.5) and 10 mM KCl at 23° C. f)
FIGURE LEGENDS
The free energy change for binding calculated from ∆G 0 ′= RT ln Kd g) The free energy change caused by removal of side chain, calculated from the difference in ∆G 0′ for Tg and the substituted analog. 2) and 100mM KCl at 23º C. Evaluated from exponential analysis of the fluorescence traces by addition of inhibitor to Ca2E1 as shown in Fig. 3 . c Missing the octanoate group at C(2). d For structures of VI -XII see Supplementary material Table S2 .
